144 related articles for article (PubMed ID: 16459340)
1. Acceptability of low molecular weight heparin thromboprophylaxis for inpatients receiving palliative care: qualitative study.
Noble SI; Nelson A; Turner C; Finlay IG
BMJ; 2006 Mar; 332(7541):577-80. PubMed ID: 16459340
[TBL] [Abstract][Full Text] [Related]
2. Factors influencing hospice thromboprophylaxis policy: a qualitative study.
Noble SI; Nelson A; Finlay IG
Palliat Med; 2008 Oct; 22(7):808-13. PubMed ID: 18772209
[TBL] [Abstract][Full Text] [Related]
3. Is long-term low-molecular-weight heparin acceptable to palliative care patients in the treatment of cancer related venous thromboembolism? A qualitative study.
Noble SI; Finlay IG
Palliat Med; 2005 Apr; 19(3):197-201. PubMed ID: 15920933
[TBL] [Abstract][Full Text] [Related]
4. The use of long-term low-molecular weight heparin for the treatment of venous thromboembolism in palliative care patients with advanced cancer: a case series of sixty two patients.
Noble SI; Hood K; Finlay IG
Palliat Med; 2007 Sep; 21(6):473-6. PubMed ID: 17846086
[TBL] [Abstract][Full Text] [Related]
5. Role of palliative low-molecular-weight heparin for treating venous thromboembolism in patients with advanced cancer.
Tran QN
Am J Hosp Palliat Care; 2010 Sep; 27(6):416-9. PubMed ID: 20197558
[TBL] [Abstract][Full Text] [Related]
6. Primary thromboprophylaxis in the palliative care setting: a qualitative systematic review.
McLean S; Ryan K; O'Donnell JS
Palliat Med; 2010 Jun; 24(4):386-95. PubMed ID: 20360427
[TBL] [Abstract][Full Text] [Related]
7. Prophylactic heparin in palliative care: ...to a challenging idea.
Chambers JC
BMJ; 2006 Mar; 332(7543):729. PubMed ID: 16565142
[No Abstract] [Full Text] [Related]
8. Prevention of venous thromboembolism in cancer patients.
Kakkar AK; Williamson RC
Semin Thromb Hemost; 1999; 25(2):239-43. PubMed ID: 10357091
[TBL] [Abstract][Full Text] [Related]
9. The effect of low molecular weight heparin thromboprophylaxis on bleeding complications after gastric cancer surgery.
Jeong O; Ryu SY; Park YK; Kim YJ
Ann Surg Oncol; 2010 Sep; 17(9):2363-9. PubMed ID: 20358302
[TBL] [Abstract][Full Text] [Related]
10. Randomized clinical trial of low molecular weight heparin with thigh-length or knee-length antiembolism stockings for patients undergoing surgery.
Howard A; Zaccagnini D; Ellis M; Williams A; Davies AH; Greenhalgh RM
Br J Surg; 2004 Jul; 91(7):842-7. PubMed ID: 15227689
[TBL] [Abstract][Full Text] [Related]
11. Have palliative care teams' attitudes toward venous thromboembolism changed? A survey of thromboprophylaxis practice across British specialist palliative care units in the years 2000 and 2005.
Noble SI; Finlay IG
J Pain Symptom Manage; 2006 Jul; 32(1):38-43. PubMed ID: 16824983
[TBL] [Abstract][Full Text] [Related]
12. Survey of the use of thromboprophylaxis in laparoscopic surgery in Denmark.
Filtenborg Tvedskov T; Rasmussen MS; Wille-Jørgensen P
Br J Surg; 2001 Oct; 88(10):1413-6. PubMed ID: 11578302
[TBL] [Abstract][Full Text] [Related]
13. Thromboprophylaxis practice patterns in two Western Australian teaching hospitals.
Eikelboom JW; Mazzarol A; Quinlan DJ; Beaver R; Williamson J; Yi Q; Hankey GJ;
Haematologica; 2004 May; 89(5):586-93. PubMed ID: 15136222
[TBL] [Abstract][Full Text] [Related]
14. [Rationalization of risk factors for venous thromboembolism in medical inpatients. A prospective study].
Pottier P; Planchon B; Truchaud F; Pistorius MA; Furic I; Grolleau JY
J Mal Vasc; 2000 Oct; 25(4):241-9. PubMed ID: 11060418
[TBL] [Abstract][Full Text] [Related]
15. Quality of life of cancer patients receiving inpatient and home-based palliative care.
Peters L; Sellick K
J Adv Nurs; 2006 Mar; 53(5):524-33. PubMed ID: 16499673
[TBL] [Abstract][Full Text] [Related]
16. Finding the evidence for thromboprophylaxis in palliative care: first let us agree on the question.
Noble S; Johnson M
Palliat Med; 2010 Jun; 24(4):359-61. PubMed ID: 20507865
[No Abstract] [Full Text] [Related]
17. Cost-effectiveness of prophylactic low molecular weight heparin in pregnant women with a prior history of venous thromboembolism.
Johnston JA; Brill-Edwards P; Ginsberg JS; Pauker SG; Eckman MH
Am J Med; 2005 May; 118(5):503-14. PubMed ID: 15866253
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of a thromboprophylaxis quality improvement project in a palliative care unit.
Legault S; Tierney S; Sénécal I; Pereira J
J Pain Symptom Manage; 2011 Mar; 41(3):503-10. PubMed ID: 21145701
[TBL] [Abstract][Full Text] [Related]
19. Use of thromboprophylaxis in palliative care patients: a survey among experts in palliative care, oncology, intensive care, and anticoagulation.
Kierner KA; Gartner V; Schwarz M; Watzke HH
Am J Hosp Palliat Care; 2008; 25(2):127-31. PubMed ID: 18198364
[TBL] [Abstract][Full Text] [Related]
20. Thromboprophylaxis for inpatients with advanced cancer in palliative care settings: A systematic review and narrative synthesis.
Cai R; Zimmermann C; Krzyzanowska M; Granton J; Hannon B
Palliat Med; 2019 May; 33(5):486-499. PubMed ID: 30819046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
